Xylem Files 8-K on Board and Officer Changes

The $28 billion water technology company disclosed leadership transitions in a regulatory filing with the SEC.

XYL · 2026-08-13 · MarginX

Leadership Transition at Water Technology Firm

Xylem Inc. filed a Form 8-K with the Securities and Exchange Commission disclosing changes to its board of directors and executive officers, according to regulatory filings made public on August 13, 2026. The Rye Brook, New York-based water technology company, which closed at $121.93 and carries a market capitalization of approximately $28 billion, provided no additional details in the publicly available headline regarding the nature or scope of the personnel changes.

Form 8-K filings are required when public companies experience material events that shareholders should know about, including changes to corporate governance structures and executive leadership.

Recent Insider Activity

MarginX data shows recent equity awards to several Xylem insiders. Jerome A. Peribere, Uday Yadav, and Victoria D. Harker each received awards of 1,711 shares, according to regulatory filings. Such awards are common components of executive compensation packages at publicly traded companies and typically vest over time subject to performance or tenure conditions.

Looking Ahead

Xylem is expected to report third-quarter 2026 results on October 30, according to MarginX data. The earnings release will provide investors with an update on the company's operational performance amid ongoing leadership changes.

The reporting period will follow two Federal Open Market Committee meetings scheduled for September 16 and October 28. The September meeting will include updated economic projections and rate decision guidance, potentially affecting market conditions for capital-intensive infrastructure companies like Xylem.

Xylem specializes in water infrastructure and technology solutions, serving municipal, industrial, and residential customers globally. The company's products and services address water transport, treatment, testing, and efficient use.

Investors and analysts will likely seek additional clarity on the leadership changes and any strategic implications when the company holds its next earnings call in late October.

This article was generated by MarginX from public news on 2026-08-13. It is not investment advice.

Go deeper on XYL — scores, valuation multiples, filings and earnings-call search on MarginX.